�At the 1st World Congress for Interventional Therapies for Type 2 Diabetes, prominent endocrinologists from around the populace will convene in an exchange with leading surgeons about the role of surgery and other rising new therapies for type 2 diabetes.
Twenty-four of the most significant Scientific Societies from the US and worldwide have endorsed the World Congress to encourage a responsible and seasonable discussion of all aspects of this emerging discipline, including its implications for public health and diabetes research.
"The American Association of Clinical Endocrinologists (AACE) is pleased to endorse the 1st World Congress on Interventional Therapies for Type 2 Diabetes" the Society said in a assertion. "AACE recognizes the need for interventions that ar proven to be secure and effective in the management of type 2 diabetes. AACE looks onward to active in this very important scientific encounter, which will critically probe the potentiality role for surgery in treating type 2 diabetes and other related metabolic disorders."
"I am excited virtually the collaboration between endocrinologists and surgeons," said Dr. Louis Aronne clinical professor of medicine at Weill Cornell Medical College. "Together along with other leading experts in diabetes and public health, the Congress will examine the emergent role of surgery, not only as a therapy for type 2 diabetes, but as a means to molt light on the causes of the disease. The lessons we are already learning from studying gI surgery experience tremendous implications for the same future of medical therapies of diabetes."
Type 2 Diabetes affects an estimated 24 zillion Americans and 246 gazillion people worldwide, a number that is expected to grow to 380 billion by 2025. Faced with the escalating global diabetes crisis, wellness care providers require potent tools for therapeutic interventions. Various types of surgery on the gastrointestinal tract constitute passing powerful options to help fight diabetes in patients with terrible obesity. The appropriate role of surgical process in the treatment of patients with type 2 diabetes has recently become a matter of intense scientific and public debate.
"Surgery has arrived like a comet across the sphere of diabetes and corpulency unexpected, brilliant, with majuscule promise for the succeeding," said Dr. Jesse Roth, Congress staff member, research worker, and diabetologist at the Feinstein Institute for Medical Research and the Albert Einstein College of Medicine of Yeshiva University in New York. "Teams of talented researchers are moving ahead to define the role of surgery in the treatment of both of these scourges."
Dr Francesco Rubino, Director of the World Congress and Chief of Metabolic Surgery at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, emphasised that surgery offers likewise a unique opportunity to improve knowledge of the mechanisms of diabetes. "Teasing out the agents creditworthy for the beneficial personal effects of gI surgery on diabetes may lead to new discoveries and provide targets for new medications or even less trespassing interventional therapies."
1ST WORLD CONGRESS ON INTERVENTIONAL THERAPIES FOR TYPE 2 DIABETES
The 1st World Congress on Interventional Therapies for Type 2 Diabetes is a comprehensive and multidisciplinary forum where leaders in the worldwide health community will carry on an organized review and discussion of the in vogue scientific information and theories on the use of bariatric surgery for the treatment of type 2 diabetes. The Congress, hosted by Weill Cornell Medical College and NewYork-Presbyterian Hospital, aims to create a forum for the medical community to work with health policy makers, including top public health government and insurers from the U.S. and around the world. The overarching drive is to craft an agenda of health policy initiatives to seize the opportunity offered by gastrointestinal surgery and novel interventional therapies for the understanding and treatment of diabetes. For more information, chew the fat http://www.interventionaldiabetology.org.
NewYork-Presbyterian Hospital
425 E 61st St., Fl. 7
New York, NY 10021
United States
http://www.nyp.org
More information
Thursday, 4 September 2008
Subscribe to:
Posts (Atom)